Diabetes – SMBG Market Access

 

Value Differentiation in a Genericised Space | Diabetes SMBG

Challenge: To understand barriers to medical communications and HCP stakeholder engagement activities in securing market access across key global emerging markets (Russia, China, Saudi Arabia, China).

Response: In a series of extended global internal stakeholder interviews, the outcomes of a range of previously-implemented initiatives and perspectives from across a range of global in-market experiences were explored. By analyzing these insights the ability to view potential structural barriers and drive future coherence across global functions when considering investment in value-add initiatives was improved.

Deliverables: Interactive Emerging Markets Value-Add Internal Playbook | Qualitative Value Assessment of Programs Deployed | Medical Communications Strategy Recommendations

See the Slide Set below (coming shortly) for more details…